Scarica l'app Stockscreener
976.57
1.53%
14.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$961.88
Aprire:
$968.07
Volume 24 ore:
769.08K
Relative Volume:
1.02
Capitalizzazione di mercato:
$113.86B
Reddito:
$403.43B
Utile/perdita netta:
$5.10B
Rapporto P/E:
25.39
EPS:
38.4657
Flusso di cassa netto:
$5.41B
1 W Prestazione:
+4.98%
1M Prestazione:
+8.56%
6M Prestazione:
+13.10%
1 anno Prestazione:
+23.32%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$925.00
$979.82
Portata 52W:
$723.68
$999.00
Mckesson Corp Stock (MCK) Company Profile
Nome
Mckesson Corp
Settore
Industria
Telefono
972-446-4800
Indirizzo
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
976.57 | 113.86B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
336.17 | 64.15B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
247.74 | 57.37B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
85.56 | 9.54B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.3751 | 1.18B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-08-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2026-04-28 | Iniziato | William Blair | Outperform |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2024-12-04 | Ripresa | Mizuho | Neutral |
| 2024-11-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | Reiterato | Leerink Partners | Outperform |
| 2024-08-08 | Reiterato | Mizuho | Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-07-06 | Downgrade | Argus | Buy → Hold |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | Reiterato | Barclays | Overweight |
| 2021-11-02 | Reiterato | BofA Securities | Buy |
| 2021-11-02 | Reiterato | Evercore ISI | Outperform |
| 2021-11-02 | Reiterato | Jefferies | Buy |
| 2021-03-30 | Aggiornamento | Argus | Hold → Buy |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-08-04 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-05-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-18 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-05 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-10-26 | Reiterato | Barclays | Equal Weight |
| 2018-07-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-02 | Reiterato | Mizuho | Neutral |
| 2018-01-24 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Mckesson Corp Borsa (MCK) Ultime notizie
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term - Zacks Investment Research
If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now - Zacks Investment Research
McKesson (MCK) Extends Key Distribution Tie Through 2032 And Expands Pharmacy Role - Simply Wall Street
McKesson Corporation (MCK) Stock forecasts - Yahoo Finance Singapore
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
How AI Adoption Could Supercharge McKesson (MCK) - Yahoo Finance Singapore
Here's Why McKesson (MCK) is a Strong Growth Stock - Zacks Investment Research
Here's Why McKesson (MCK) Fell More Than Broader Market - Zacks Investment Research
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes" - Zacks Investment Research
What Is McKesson (MCK) Gaining From This $5.8 Billion Option Care Deal? - Yahoo Finance
Option Care stock surges on McKesson’s home-infusion bet - TheStreet
CD&R And McKesson To Acquire Option Care Health For $5.8 Billion - Pulse 2.0
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Yahoo Finance
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - Zacks Investment Research
McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout - finchannel
McKesson, private equity firm buy home infusion company, Option Care Health - Managed Healthcare Executive
McKesson Just Put $32.05 Cash on America's Biggest Home Infusion Name - Money Morning
McKesson Corporation (MCK) Stock Forecasts - Yahoo Finance
Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid - Yahoo Finance
Why Option Care Health Stock Skyrocketed on Tuesday - The Motley Fool
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal - Yahoo Finance
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
CD&R, McKesson acquiring infusion therapy provider Option Care Health for $5.8B - Fierce Healthcare
McKesson, CD&R to buy Option Care Health for $5.8 billion - Modern Healthcare
Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share - Yahoo Finance
McKesson Buys Home Infusion Company Option Care for $5.8B - HomeCare
McKesson, CD&R to Buy Option Care in $5.8 Billion Deal - Bloomberg.com
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion - WSJ
CD&R, McKesson Corporation sign agreement to acquire Option Care Health - MLex
OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeover (OPCH:NASDAQ) - Seeking Alpha
Cd&R And Mckesson Corporation Sign Agreement To Acquire Option Care Health - TradingView
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal - Yahoo Finance
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health - Yahoo Finance
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Yahoo Finance
Option Care Jumps on Report McKesson Is Preparing an Offer - Bloomberg.com
McKesson and CD&R strike $5.8bn deal to buy infusion services provider - Financial Times
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
Company News for Oct 2, 2026 - Zacks Investment Research
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - Zacks Investment Research
McKesson stock falls 1.19 percent as targets split - AD HOC NEWS
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
McKesson (MCK) Lifted Its Guidance, Is The Stock Still 11% Undervalued? - finance.yahoo.com
McKesson (MCK) Stock Forecast and Price Target 2026 $MCK - MarketBeat
McKesson stock heads into the open after a 0.1 percent gain - AD HOC NEWS
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson 5-year return hits 34.23%, beating market by 22.21% - scanx.trade
Mckesson Corp Azioni (MCK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mckesson Corp Azioni (MCK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lerman Bradley E | Director |
Aug 10 '26 |
Sale |
892.33 |
301 |
268,590 |
0 |
| Lerman Bradley E | Director |
Aug 10 '26 |
Proposed Sale |
892.32 |
301 |
268,589 |
0 |
| Vitalone Britt J. | Former Officer |
Aug 03 '26 |
Proposed Sale |
843.31 |
7,925 |
6,683,192 |
0 |
| TYLER BRIAN S. | Chief Executive Officer |
Jul 07 '26 |
Sale |
793.56 |
8,463 |
6,715,898 |
5,919 |
| TYLER BRIAN S. | Officer |
Jul 07 '26 |
Proposed Sale |
793.56 |
8,463 |
6,715,898 |
0 |
| TYLER BRIAN S. | Officer |
Jun 17 '26 |
Proposed Sale |
775.13 |
8,463 |
6,559,925 |
0 |
| TYLER BRIAN S. | Chief Executive Officer |
Jun 17 '26 |
Sale |
775.13 |
8,463 |
6,559,925 |
14,382 |
| TYLER BRIAN S. | Officer |
Jun 09 '26 |
Proposed Sale |
763.00 |
4,929 |
3,760,827 |
0 |
| TYLER BRIAN S. | Chief Executive Officer |
Jun 09 '26 |
Sale |
763.00 |
4,929 |
3,760,827 |
22,845 |
| Rutledge Napoleon B JR | SVP, Controller & CAO |
Jun 05 '26 |
Sale |
764.00 |
133 |
101,612 |
632 |
1.84%
5.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):